Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death
Peng Zhao(Northwest A&F University), Jian‐Qiang Yu(Ningxia Medical University), Tao Sun(Wuhan University), Yu‐Xiang Li(Ningxia Medical University), Ru Zhou(Ningxia Medical University), Yang Niu(Ningxia Medical University), Shujing Wang(Anhui Medical University), Haining Li(Ningxia Medical University), Wanxia Yao(Ningxia Medical University), Hai-Qi Qiao(Ningxia Medical University)
Cited by 66
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
|npj Precision Oncology|2024|535
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC
|New England Journal of Medicine|2024|369
Genome-wide analysis of the potato Hsp20 gene family: identification, genomic organization and expression profiles in response to heat stress
|BMC Genomics|2018|267
Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms
|Molecular Pharmaceutics|2015|165